Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

NCT04382937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus Infection

Interventions

DRUG: P1101 + Ribavirin
DRUG: PEG-Intron + Ribavirin

Sponsor

PharmaEssentia